Markets:

Overview

News

Currencies

International

Treasuries

Merit Medical Systems, Inc. - Common Stock (NQ:MMSI)

73.49 -0.67 (-0.90%)

Streaming Delayed Price Updated: 4:00 PM EST, Mar 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Merit Medical Systems, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Merit Medical Systems Q2 Beat Expectations: Analysts Say China/Russia Headwinds Hamper Guidance Raise ↗

July 26, 2023

Tuesday, Merit Medical Systems Inc (NASDAQ: MMSI) announced Q2 FY23 revenue of $320.1 million, up 8.5% Y/Y, beating the

Via Benzinga

Why Universal Health Services Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 26, 2023

Gainers Silicon Motion Technology Corporation (NASDAQ: SIMO) shares climbed 78.9% to $93.40 following a report suggesting China approval of the company's Maxlinear merger.

Via Benzinga

The Latest Analyst Ratings for Merit Medical Systems ↗

July 06, 2023

Via Benzinga

Where Merit Medical Systems Stands With Analysts ↗

June 09, 2023

Via Benzinga

Analyst Ratings for Merit Medical Systems ↗

May 08, 2023

Via Benzinga

Merit Medical To See Sustained Revenue Growth Despite Macro Headwinds, Bullish Analyst Says ↗

April 27, 2023

Via Benzinga

3 Top Healthcare Stocks to Buy for July ↗

July 07, 2023

Three medical device stocks that make solid long-term investments.

Via The Motley Fool

Merit Medical's Recent M&A Efforts Set To Show Early Impact In FY24: Analyst Insight ↗

July 06, 2023

Barrington Research analyst Michael Petusky reiterated an Outperform rating on Merit Medical Systems, Inc. (NASDAQ: MMSI), with a

Via Benzinga

Future Of Merit Medical Systems: Analyst Predictions On Revenue Growth And Operating Margin Improvement ↗

June 09, 2023

Needham analyst Mike Matson reiterated a Buy rating on the shares of Merit Medical Systems, Inc. (NASDAQ: MMSI),

Via Benzinga

AngioDynamics Divests Dialysis Portfolio And Biopsy Product Line To Merit Medical Systems For $100M ↗

June 09, 2023

AngioDynamics, Inc. (NASDAQ: ANGO)

Via Benzinga

Top 5 Health Care Stocks That Should Keep You Up At Night ↗

May 23, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Chart Of The Day: Merit Medical Systems - Strong Buy Sentiment ↗

May 04, 2023

Revenue is predicted to grow 6.20% this year and another 5.30% next year. Earnings are estimated to increase by 7.40% this year, and an additional 10.00% next year.

Via Talk Markets

Analyst Ratings for Merit Medical Systems ↗

April 17, 2023

Via Benzinga

Earnings Scheduled For October 28, 2021 ↗

October 28, 2021

Companies Reporting Before The Bell • LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million. •...

Via Benzinga

Earnings Scheduled For February 22, 2023 ↗

February 22, 2023

Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2022 ↗

December 20, 2022

Via Benzinga

Lantheus Holdings Stock Showing Market Leadership; Earns 94 RS Rating ↗

November 29, 2022

Lantheus Holdings stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 90 to 94.

Via Investor's Business Daily

Merit Medical Systems: Q3 Earnings Insights ↗

October 26, 2022

Merit Medical Systems (NASDAQ:MMSI) reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

December 01, 2022

During Thursday's session, 108 stocks hit new 52-week highs.

Via Benzinga

A Preview Of Merit Medical Systems's Earnings ↗

October 25, 2022

Merit Medical Systems (NASDAQ:MMSI) is set to give its latest quarterly earnings report on Wednesday, 2022-10-26. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Recap: Merit Medical Systems Q2 Earnings ↗

July 27, 2022

Merit Medical Systems (NASDAQ:MMSI) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

Merit Medical Bullish On FY23 Operating Margin Of 18-21%, Needham Says Could Exceed ↗

April 18, 2022

At the Annual Needham Healthcare Conference, Merit Medical Systems Inc's (NASDAQ: MMSI) management said that inflationary pressures and supply chain issues have been manageable and have not had a...

Via Benzinga

Merger Arbitrage Mondays - Google (GOOG) Acquires Cybersecurity Firm Mandiant (MNDT) ↗

March 14, 2022

Merger activity declined last week with three new deals announced and five deals completed. Two of the three new deals announced were potential deals in the works. I was surprised...

Via Benzinga

Medical Device Maker Merit Medical Mulls Sale: Reuters ↗

March 10, 2022

Merit Medical Systems Inc (NASDAQ: MMSI) is exploring options that include an outright sale to a private equity firm, Reuters reported citing people familiar with the...

Via Benzinga

Recap: Merit Medical Systems Q4 Earnings ↗

February 24, 2022

Merit Medical Systems (NASDAQ:MMSI) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:05 PM. Here's what investors need to know about the announcement....

Via Benzinga

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company ↗

February 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...

Via Benzinga

Merit Medical Systems Inc (MMSI) Q3 2021 Earnings Call Transcript ↗

October 28, 2021

MMSI earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug ↗

October 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In...

Via Benzinga

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More ↗

October 24, 2021

Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.